Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial

Emergence of an Extensively Drug-Resistant <i>Salmonella enterica</i> Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins

Elizabeth J. Klemm, Sadia Shakoor, Andrew J. Page et al. · mBio · 2018 · 622 citations · Full text

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment

Vittal Mogasale, Brian Maskery, R. Leon Ochiai et al. · The Lancet Global Health · 2014 · 573 citations · Full text

Preventive Medicine, Risk-factor Adjustment, Health Economics +12

The Efficacy of a<i>Salmonella typhi</i>Vi Conjugate Vaccine in Two-to-Five-Year-Old Children

Feng Lin, Vô Anh Hó, Ha Ba Khiem et al. · New England Journal of Medicine · 2001 · 470 citations · Full text

The burden of typhoid fever in low- and middle-income countries: A meta-regression approach

Marina Antillón, Joshua L. Warren, Forrest W. Crawford et al. · PLoS neglected tropical diseases · 2017 · 338 citations · Full text

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

Vineeth Varanasi, Anit Singh, Marcela F. Pasetti et al. · Clinical Infectious Diseases · 2015 · 199 citations · Full text